当前位置:首页 - 行情中心 - 日科化学(300214) - 财务分析 - 利润表

日科化学

(300214)

  

流通市值:36.26亿  总市值:36.26亿
流通股本:4.65亿   总股本:4.65亿

利润表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、营业总收入912,958,078.533,741,849,463.532,826,848,472.821,957,070,237.88
  营业收入912,958,078.533,741,849,463.532,826,848,472.821,957,070,237.88
二、营业总成本916,887,779.23,752,618,132.452,859,520,083.821,981,280,459.49
  营业成本846,972,418.313,484,730,451.842,695,190,262.311,876,056,133.74
  税金及附加6,076,755.222,678,751.2518,809,805.7813,234,697.8
  销售费用8,996,348.9337,982,908.1626,572,838.417,739,150.98
  管理费用29,057,855.9107,770,367.5860,614,841.4738,985,355.49
  研发费用9,093,005.6247,561,712.3327,742,565.6416,445,070.05
  财务费用16,691,395.2451,893,941.2930,589,770.2218,820,051.43
  其中:利息费用11,578,846.0444,633,925.4332,862,077.4423,419,169.37
  其中:利息收入952,167.222,548,755.971,183,248.09859,579.68
三、其他经营收益
  加:公允价值变动收益00-0
  加:投资收益2,103,607.1941,747.211,850,016.241,387,817.52
  净敞口套期收益00-0
  资产处置收益3,121,167.353,860,589.064,276,463.95130,838.57
  资产减值损失(新)0-9,097,990.2217,604,733.2814,213,209.76
  信用减值损失(新)1,638,012.32-1,045,266.31-2,124,988.45-3,592,818.26
  其他收益2,627,667.112,807,076.827,567,707.114,906,710.53
四、营业利润5,560,753.2-3,302,512.36-3,497,678.87-7,164,463.49
  加:营业外收入39,765.18515,154.545,593.1273,180.59
  减:营业外支出397,377.651,373,507.161,614,767.83309,609.12
五、利润总额5,203,140.73-4,160,865.02-5,066,853.58-7,400,892.02
  减:所得税费用1,122,892.0530,905,358.13-5,578,181.64-5,040,068.95
六、净利润4,080,248.68-35,066,223.15511,328.06-2,360,823.07
(一)按经营持续性分类
  持续经营净利润4,080,248.68-35,066,223.15511,328.06-2,360,823.07
(二)按所有权归属分类
  归属于母公司股东的净利润2,077,680.19-29,707,578.344,016,187.891,156,070.76
  少数股东损益2,002,568.49-5,358,644.81-3,504,859.83-3,516,893.83
  扣除非经常损益后的净利润723,806.31-38,155,856.48599,032.92-123,646.98
七、每股收益
  (一)基本每股收益0-0.060.010
  (二)稀释每股收益0-0.060.010
九、综合收益总额4,080,248.68-35,066,223.15511,328.06-2,360,823.07
  归属于母公司股东的综合收益总额2,077,680.19-29,707,578.344,016,187.891,156,070.76
  归属于少数股东的综合收益总额2,002,568.49-5,358,644.81-3,504,859.83-3,516,893.83
公告日期2026-04-272026-04-272025-10-232025-08-26
审计意见(境内)标准无保留意见
TOP↑